Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy
- PMID: 21177893
- PMCID: PMC3067719
- DOI: 10.1128/JCM.01885-10
Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy
Abstract
Sepsis caused by fluoroquinolone-resistant Escherichia coli is a risk for patients undergoing an ultrasound-guided, transrectal prostate biopsy. A method incorporating selective broth and media was evaluated using rectal swabs obtained from 136 patients prior to a biopsy procedure. Fluoroquinolone-resistant organisms were isolated from 22% of the patients included in this study.
Comment in
-
Reply by Authors: "Prospective Monitoring and Adapting Strategies for Prevention of Infection Following Transrectal Prostate Procedures".Urol Pract. 2018 Mar;5(2):131. doi: 10.1016/j.urpr.2017.03.019. Urol Pract. 2018. PMID: 32632373 Free PMC article. No abstract available.
References
-
- Batura D., Rao G. G., Nielsen P. B. 2010. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int. 106:1017–1020 - PubMed
-
- Feliciano J., et al. 2008. The incidence of fluoroquinolone resistant infections after prostate biopsy—are fluoroquinolones still effective prophylaxis? J. Urol. 179:952–955; discussion, 955 - PubMed
-
- Hodge K. K., McNeal J. E., Stamey T. A. 1989. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J. Urol. 142:66–70 - PubMed
-
- Horcajada J. P., et al. 2009. High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. Urology 74:1195–1199 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
